Related references
Note: Only part of the references are listed.ANIMAL MODELS FOR THE STUDY OF LEISHMANIASIS IMMUNOLOGY
Elsy Nalleli Loria-Cervera et al.
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO (2014)
Leishmaniasis: Vaccine candidates and perspectives
Bhawana Singh et al.
VACCINE (2012)
T helper1/T helper2 cells and resistance/susceptibility to Leishmania infection: is this paradigm still relevant?
James Alexander et al.
FRONTIERS IN IMMUNOLOGY (2012)
Studies on the protective efficacy and immunogenicity of Hsp70 and Hsp83 based vaccine formulations in Leishmania donovani infected BALB/c mice
Jaspreet Kaur et al.
ACTA TROPICA (2011)
Qualitative differences in the early immune response to live and killed Leishmania major: Implications for vaccination strategies against Leishmaniasis
Ifeoma Okwor et al.
VACCINE (2009)
Leishmania major infection in susceptible and resistant mice elicit a differential humoral response against a total soluble fraction and defined recombinant antigens of the parasite
Virginia Iniesta et al.
PARASITOLOGY RESEARCH (2008)
Leishmania amazonensis:: Humoral response to amastigote excreted-antigens in murine leishmaniasis
Concepcion Hernandez-Chinea
EXPERIMENTAL PARASITOLOGY (2007)
What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery?
A Campos-Neto
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2005)
Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen
P Tewary et al.
VACCINE (2004)
DNA-Salmonella enterica serovar Typhimurium primer-booster vaccination biases towards T helper 1 responses and enhances protection against Leishmania major infection in mice
UG Lange et al.
INFECTION AND IMMUNITY (2004)
Molecular characterization of a novel amastigote stage specific Class I nuclease from Leishmania major
S Farajnia et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2004)
IgG subclass responses in a longitudinal study of canine visceral leishmaniasis
RJ Quinnell et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2003)
The Leishmania infantum acidic ribosomal protein P0 administered as a DNA vaccine confers protective immunity to Leishmania major infection in BALB/c mice
S Iborra et al.
INFECTION AND IMMUNITY (2003)
The immunology of susceptibility and resistance to Leishmania major in mice
D Sacks et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL® adjuvant
YAW Skeiky et al.
VACCINE (2002)
Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response
C Kébaïer et al.
INFECTION AND IMMUNITY (2001)
The Leishmania infantum acidic ribosomal protein LiP2a induces a prominent humoral response in vivo and stimulates cell proliferation in vitro and interferon-gamma (IFN-γ) production by murine splenocytes
M Soto et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
Share Paper
